Cargando…

Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus

INTRODUCTION: Fibroblast growth factor (FGF) 21 is an important regulator of glycemic control, but the association between circulating FGF21 and diabetic complications is poorly understood. Moreover, basal FGF21 secretion, especially in response to insulin dose, in patients with type 1 diabetes mell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taniguchi, Hirokazu, Nirengi, Shinsuke, Ishihara, Kengo, Sakane, Naoki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863253/ https://www.ncbi.nlm.nih.gov/pubmed/35192641 http://dx.doi.org/10.1371/journal.pone.0263774

Ejemplares similares

Comparisons Between Serum Levels of Hepcidin and Leptin in Male College-Level Endurance Runners and Sprinters
por: Nirengi, Shinsuke, et al.
Publicado: (2021)

Association Between Serum Apolipoprotein A1 Levels, Ischemic Stroke Subtypes and Plaque Properties of the Carotid Artery
por: Ohtani, Ryo, et al.
Publicado: (2020)

Safety of the batteries and power units used in insulin pumps: A pilot cross‐sectional study by the Association for the Study of Innovative Diabetes Treatment in Japan
por: Murata, Takashi, et al.
Publicado: (2017)

The relationship between serum adipokine fibroblast growth factor‐21 and gestational diabetes mellitus
por: Jia, Xiaojiao, et al.
Publicado: (2022)

Fibroblast Growth Factor 21 in Gestational Diabetes Mellitus and Type 2 Diabetes Mellitus
por: Gawlik, Katarzyna, et al.
Publicado: (2023)

Lower bone mineral density and higher bone resorption marker levels in premenopausal women with type 1 diabetes in Japan
por: Yoshioka, Fumi, et al.
Publicado: (2021)

Assessment of fibroblast growth factor 21 in children with type 1 diabetes mellitus in relation to microvascular complications
por: Tantawy, Nermien M., et al.
Publicado: (2023)

Effects of beta-conglycinin intake on circulating FGF21 levels and brown adipose tissue activity in Japanese young men: a single intake study and a randomized controlled trial
por: Taniguchi, Hirokazu, et al.
Publicado: (2020)

Effects of a Low Advanced Glycation End Products Diet on Insulin Levels: The Feasibility of a Crossover Comparison Test
por: Sukino, Shin, et al.
Publicado: (2018)

Serum Concentrations of Fibroblast Growth Factors 19 and 21 in Women with Gestational Diabetes Mellitus: Association with Insulin Resistance, Adiponectin, and Polycystic Ovary Syndrome History
por: Wang, Dongyu, et al.
Publicado: (2013)

Correlation between reactive oxygen metabolites & atherosclerotic risk factors in patients with type 2 diabetes mellitus
por: Kotani, Kazuhiko, et al.
Publicado: (2013)

Serum Levels of Fibroblast Growth Factor 21 Are Positively Associated with Aortic Stiffness in Patients with Type 2 Diabetes Mellitus
por: Huang, Sin-Yi, et al.
Publicado: (2021)

Serum Fibroblast Growth Factor 21 Levels Are Correlated with the Severity of Diabetic Retinopathy
por: Lin, Yuan, et al.
Publicado: (2014)

The relationship between serum levels of fibroblast growth factor 21 and diabetic retinopathy
por: Mousavi, Zohre, et al.
Publicado: (2017)

Diagnostic accuracy of the anti‐glutamic acid decarboxylase antibody in type 1 diabetes mellitus: Comparison between radioimmunoassay and enzyme‐linked immunosorbent assay
por: Murata, Takashi, et al.
Publicado: (2017)

Fibroblast growth factor-21 (FGF21) analogs as possible treatment options for diabetes mellitus in veterinary patients
por: Corbee, Ronald J., et al.
Publicado: (2023)

Plasma Levels of Myonectin But Not Myostatin or Fibroblast-Derived Growth Factor 21 Are Associated with Insulin Resistance in Adult Humans without Diabetes Mellitus
por: Toloza, Freddy J. K., et al.
Publicado: (2018)

The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms
por: Xiao, Mengjie, et al.
Publicado: (2021)

Effects of obesity, metabolic syndrome, and non‐alcoholic or alcoholic elevated liver enzymes on incidence of diabetes following lifestyle intervention: A subanalysis of the J‐DOIT1
por: Sakane, Naoki, et al.
Publicado: (2020)

Self-weighing frequency and the incidence of type 2 diabetes: post hoc analysis of a cluster-randomized controlled trial
por: Sakane, Naoki, et al.
Publicado: (2020)

Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy
por: Ishihara, Hisamitsu, et al.
Publicado: (2019)

Therapeutic Effects of Fibroblast Growth Factor-21 on Diabetic Nephropathy and the Possible Mechanism in Type 1 Diabetes Mellitus Mice
por: Weng, Wenya, et al.
Publicado: (2020)

Seasonal differences in brown adipose tissue density and pulse rate variability in a thermoneutral environment
por: Nirengi, Shinsuke, et al.
Publicado: (2018)

Maslinic acid derived from olive fruit in combination with resistance training improves muscle mass and mobility functions in the elderly
por: Nagai, Narumi, et al.
Publicado: (2019)

Fibroblast growth factor 21 as a candidate of a novel serum biomarker for mitochondrial diabetes
por: Komorita, Yuji, et al.
Publicado: (2023)

Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications
por: Ashrafizadeh, Milad, et al.
Publicado: (2022)

The study of metabolic improvement by nutritional intervention controlling endogenous GIP (Mini Egg study): a randomized, cross-over study
por: Sakane, Naoki, et al.
Publicado: (2019)

Gestational Diabetes Mellitus Complicated by Hemolysis, Elevated Liver Enzymes, and Low Platelet Count After Decreased Need for Insulin: 2 Cases
por: Kawarai, Yoshimasa, et al.
Publicado: (2021)

Fibroblast Growth Factor 21 and Its Association With Oxidative Stress and Lipid Profile in Type 2 Diabetes Mellitus
por: Aleem, Mudassar, et al.
Publicado: (2021)

Fibroblast Growth Factor 21 Levels Exhibit the Association With Renal Outcomes in Subjects With Type 2 Diabetes Mellitus
por: Chang, Li-Hsin, et al.
Publicado: (2022)

Association between serum magnesium and common complications of diabetes mellitus
por: Zhang, Yiyan, et al.
Publicado: (2018)

Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
por: Xiao, Yang, et al.
Publicado: (2015)

Diurnal variations of brown fat thermogenesis and fat oxidation in humans
por: Matsushita, Mami, et al.
Publicado: (2021)

Insulin‐dependent diabetes mellitus in older adults: Current status and future prospects
por: Ikegami, Hiroshi, et al.
Publicado: (2022)

Fat (max) as an index of aerobic exercise performance in mice during uphill running
por: Ishihara, Kengo, et al.
Publicado: (2018)

Effects of Short-Term Continuous Subcutaneous Insulin Infusion on Fasting Plasma Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Yang, Mengliu, et al.
Publicado: (2011)

Fibroblast growth factor 21 resistance is associated with body shape in patients with type 2 diabetes complicating hypertension
por: Gan, Jing, et al.
Publicado: (2023)

The Insulin Treatment of Diabetes Mellitus
Publicado: (1924)

Pancreatic Insulin in Diabetes Mellitus
por: Turtle, John R.
Publicado: (1971)

Association between serum fibroblast growth factor 21 level and sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes
por: Jin, Shi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t6mthm74ibtfpsoft0so02qbtj